Beijing, China · Founded 2019 · Privately Held (backing)
Developer of immunotherapy intended to cure solid tumors. GRIT Biotechnology is based in Beijing, China and was founded in 2019. Its last reported valuation was $291 million in Oct 2025. It has raised $124 million.
Last reported valuation
$291.3M
Oct 2026
Priced at
—
Total raised
$124.2M
Last round
—
Team — not yet on record
No current team members for GRIT Biotechnology are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GRIT Biotechnology with a free account
·The complete investor list: 22 names
·Watch GRIT Biotechnology: the Monday email on marks, rounds and moves
